Skip to main navigation Skip to search Skip to main content

Supramolecular oral delivery technologies for polypeptide-based drugs

  • Harbin Institute of Technology Shenzhen
  • Harbin Institute of Technology
  • Shenzhen Shinehigh Innovation Technology Co., Ltd.
  • Ltd.

Research output: Contribution to journalArticlepeer-review

Abstract

Oral supramolecular drug delivery systems (SDDSs) have shown promising potential, along with a rapid increase in the development of polypeptide-based drugs. Biofriendly, biocompatible, and multistimulation-responsive SDDSs achieve their unique deliverability via noncovalent bonds, which can encapsulate drugs and release them at the target site along the oral tract. In this review, we analyze the oral tract from an anatomical perspective and explain the potential physical, microenvironmental, and systematic barriers, as well as the properties of drug delivery. After understanding the specific environment at different oral sites, the application of SDDSs to the mouth, stomach, small intestine, and cell targeting is summarized. Finally, this review summarizes the application of SDDSs for the successful delivery of drugs and describes how to overcome the barriers of SDDSs in drug delivery using a more biofriendly approach.

Original languageEnglish
Article number113549
JournalJournal of Controlled Release
Volume381
DOIs
StatePublished - 10 May 2025
Externally publishedYes

Keywords

  • Drug delivery system
  • Oral administration
  • Supramolecular interactions
  • Supramolecule

Fingerprint

Dive into the research topics of 'Supramolecular oral delivery technologies for polypeptide-based drugs'. Together they form a unique fingerprint.

Cite this